JPH0584289A - Wound coating material - Google Patents

Wound coating material

Info

Publication number
JPH0584289A
JPH0584289A JP27182291A JP27182291A JPH0584289A JP H0584289 A JPH0584289 A JP H0584289A JP 27182291 A JP27182291 A JP 27182291A JP 27182291 A JP27182291 A JP 27182291A JP H0584289 A JPH0584289 A JP H0584289A
Authority
JP
Japan
Prior art keywords
wound
temperature
porous
water
wound dressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP27182291A
Other languages
Japanese (ja)
Inventor
Mitsuo Okano
光夫 岡野
Mikio Koide
幹夫 小出
Yukio Kiyota
由紀夫 清田
Masato Onishi
誠人 大西
Kenichi Shimura
賢一 志村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP27182291A priority Critical patent/JPH0584289A/en
Publication of JPH0584289A publication Critical patent/JPH0584289A/en
Pending legal-status Critical Current

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

PURPOSE:To provide the coating material which adheres tightly to a wound surface and can accelerate the regeneration of the skin when applied to the wound and peels easily without sticking to the wound surface when the coating material is heated or cooled particularly at the time of removal. CONSTITUTION:This wound coating material is constituted by coating the one surface of a porous polyolefin film or porous hologenated polyolefin film with a temp. sensitive high polymer having the lower limit critical solution temp. to water within a 0 to 35 deg.C range.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、創傷、熱傷等による皮
膚欠損受傷の際、該皮膚欠損部位に適用され、該皮膚欠
損部位と接する創面と固着せず、治癒に伴なって容易に
剥離可能な創傷被覆材に関する。
BACKGROUND OF THE INVENTION The present invention is applied to a skin defect due to a wound, a burn, etc., and is applied to the skin defect site, does not adhere to the wound surface in contact with the skin defect site, and easily peels off with healing. To possible wound dressings.

【0002】[0002]

【従来の技術】外傷性の皮膚創傷および採皮創等の創傷
および疾患に伴う創部に対する創傷治癒方法としては、
大別して創傷部を乾燥状態に保ち、痂皮を形成させて治
癒を行ういわゆるdry dressingと、適度の
湿潤環境をつくり、速やかな表皮細胞の遊走を行うwe
t dressingとが知られており、前者は浸出液
の貯留が少なく、感染が起こりにくく、また後者は創傷
の治癒も速やかであり、創傷部表面の乾燥壊死が少な
く、創面の保護効果も有することなどが知られている。
2. Description of the Related Art As a wound healing method for a wound such as a traumatic skin wound or a bark and a wound associated with a disease,
Broadly classified, so-called dry dressing that keeps the wound in a dry state and forms crust to heal, and creates a moderately moist environment to rapidly migrate epidermal cells.
Known as t dressing, the former has less retention of exudate and is less susceptible to infection, and the latter has faster wound healing, less dry necrosis on the wound surface, and also has a protective effect on the wound surface. It has been known.

【0003】従来はガーゼ,脱脂綿が用いられていた
が、浸出液を速やかに吸収するために、創傷面が脱水症
状になり乾燥してしまい、その結果痂皮ができる。この
際にガーゼが創面に固着して離れにくく、剥す際に患者
に苦痛を与えてしまい、出血等を伴うものである。また
滲出液がガーゼを通して表面に出てくると、細菌が傷に
侵入する可能性が考えられる。
Conventionally, gauze and absorbent cotton have been used, but since the exudate is quickly absorbed, the wound surface becomes dehydrated and becomes dry, resulting in crusting. At this time, the gauze adheres to the wound surface and is difficult to separate, which causes pain to the patient when peeled off, which is accompanied by bleeding and the like. If exudate comes out to the surface through gauze, bacteria may enter the wound.

【0004】これに代わるものとして、吸湿性パッドと
非固着性フィルムからなるスポンジ状パッドと防水性絆
創膏を組み合わせたドレッシング(Airstri
,Smith & Nephew Limite
d)や高水蒸気透過性を有するポリウレタンフィルムと
接着剤層からなる接着性ドレッシング(Op−Site
,Smith & Nephew Limited;
Bioclusive,Johnson & Jo
hnson;Tegaderm3M)などが市販され
ている。また、被覆材の創傷部と接触する部位にコラー
ゲン、キチン、フィブリン等の生体高分子を用いるも
の、あるいはゴム系の素材中に保湿成分を分散させ密着
・非癒着・高含水状態の確保などを図ったもの、さらに
は本発明者らが以前提案した創傷部に接触する部位の少
なくとも一部が撥水性物質により被覆された生体適合性
のヒドロゲル形成性の支持層(例えば、カルボキシメチ
ルセルロース、アルギン酸塩系、ヒアルロン酸塩系、ポ
リ(メタ)アクリル酸塩系)と、該支持層の創傷部に接
触する部位とは反対側に形成された水分透過調節層とか
らなる創傷被覆材(特開昭62−183760号公報)
等があり、一定の成果をおさめている。
As an alternative to this, a dressing (Airstri) combining a hygroscopic pad, a sponge-like pad made of a non-adhesive film, and a waterproof adhesive plaster is used.
p R , Smith & Nephew Limite
d) or an adhesive dressing (Op-Site) comprising a polyurethane film having high water vapor permeability and an adhesive layer.
R , Smith & New Limited Limited;
Bioplusive R , Johnson & Jo
hson; Tegaderm R 3M) and the like are commercially available. In addition, those that use biopolymers such as collagen, chitin, fibrin, etc. in the part of the dressing that comes into contact with the wound site, or by dispersing the moisturizing component in a rubber-based material to ensure adhesion, non-adhesion, high water content etc. The biocompatible hydrogel-forming support layer (for example, carboxymethylcellulose, alginate, etc.) in which at least a part of the site of the present invention, which has been previously proposed by the present inventors, is coated with a water-repellent substance. System, hyaluronate system, poly (meth) acrylate system), and a wound dressing material comprising a water permeation control layer formed on the side of the support layer opposite to the site in contact with the wound site (Japanese Patent Laid-Open Publication No. Sho. No. 62-183760)
Etc., and has achieved some results.

【0005】一方、dry dressingとして多
孔質高分子膜があるが、この場合dressingが創
面に固着してしまい剥す際に出血を伴う為、最近では創
面と接触する部位には非粘着性多孔フィルム(Melo
lin,Smith &Nephew Limite
d)を使用したドレッシングが市販されている。
On the other hand, as a dry dressing, there is a porous polymer film. In this case, however, the dressing adheres to the wound surface and causes bleeding when peeled off. Therefore, recently, a non-adhesive porous film ( Melo
lin R , Smith & Nephew Limite
Dressings using d) are commercially available.

【0006】[0006]

【発明が解決しようとする課題】上記従来の被覆材もあ
る程度の効果は有しているが、創傷部と接触する部分の
生体適合性を有する基材層の形成に用いられている材料
が、分解、脱落しやすく、創傷被覆材としての使用時に
おける物性に問題があり、さらにその分解、離脱物が異
物として認識されることがあり、創傷部の治癒を遅延さ
せる危険性があった。
Although the above-mentioned conventional covering materials also have some effects, the material used for forming the biocompatible base material layer of the portion in contact with the wound is It is easy to decompose and fall off, and there is a problem in the physical properties when used as a wound dressing material, and the decomposed and detached material may be recognized as a foreign matter, which may delay the healing of the wound.

【0007】そこで、本発明は創面への良好な密着性を
有し、創傷部と接触しても容易に分解、離脱することが
なく、創面の治癒に伴い、剥す際の出血を伴なわないで
容易に剥すことができる創傷被覆材を提供することを目
的とする。
Therefore, the present invention has good adhesion to the wound surface, does not easily decompose and detach even when contacted with a wound, and does not cause bleeding when peeling as the wound surface heals. It is an object of the present invention to provide a wound dressing which can be easily peeled off with.

【0008】[0008]

【課題を解決するための手段】上記目的は下記の構成を
有する創傷被覆材によって達成される。
The above object is achieved by a wound dressing having the following constitution.

【0009】(1)多孔質ポリオレフィン膜あるいは多
孔質ハロゲン化ポリオレフィン膜の一方の表面に、水に
対する下限臨界溶解温度が0〜35℃の範囲にある温度
感応性高分子を被覆してなる創傷被覆材。
(1) Wound covering prepared by coating one surface of a porous polyolefin membrane or a porous halogenated polyolefin membrane with a temperature-sensitive polymer having a lower critical solution temperature in water in the range of 0 to 35 ° C. Material.

【0010】(2)空孔率50%以下、平均孔径0.0
1〜1.0μmである多孔質ポリオレフィン膜あるいは
多孔質ハロゲン化ポリオレフィン膜からなり、その表面
および孔内面を、水に対する下限臨界溶解温度が0〜3
5℃の範囲にある温度感応性高分子で被覆してなる創傷
被覆材。
(2) Porosity 50% or less, average pore diameter 0.0
It is composed of a porous polyolefin membrane or a porous halogenated polyolefin membrane having a thickness of 1 to 1.0 μm, and has a lower critical dissolution temperature in water of 0 to 3 on its surface and pore inner surface.
A wound dressing material coated with a temperature-sensitive polymer in the range of 5 ° C.

【0011】(3)1項の創傷被覆材に生理活性物質を
含有させた創傷被覆材。
(3) A wound dressing containing the physiologically active substance in the wound dressing according to item 1.

【0012】本発明において水に対する上限臨界溶解温
度とは、その温度より高い温度では水に溶解するが、そ
の温度以下の温度では水に溶解せず、水とは二層に分か
れる温度をいう。また、水に対する下限臨界溶解温度と
は、その温度より高い温度では水に溶解せず、水と接触
してもこれに溶解せず二層に分かれるが、その温度以下
では水に溶解する温度をいう。上記の性質を有する高分
子で創傷被覆材を被覆した場合には、除去時に該被覆材
を上限もしくは下限臨界溶解温度以上または以下に加温
または冷却することにより、被覆材表面が水溶性となる
ので容易に被覆材を剥離することができ、創面を痛めた
り、苦痛を与えることがない。さらに、基材表面の親水
性、疎水性のバランスを容易にコントロールすることが
でき、含有されている生理活性物質の基材からの放出を
制御することができる。
In the present invention, the upper limit critical dissolution temperature in water means a temperature at which the water is dissolved at a temperature higher than that temperature, but is not dissolved at a temperature below that temperature, and the water is divided into two layers. Further, the lower critical solution temperature for water is not dissolved in water at a temperature higher than that temperature, and does not dissolve in water even if it comes into contact with water to be divided into two layers, but below that temperature, the temperature at which it is dissolved in water Say. When a wound dressing is coated with a polymer having the above properties, the surface of the dressing becomes water-soluble by heating or cooling the dressing above or below the upper or lower critical solution temperature during removal. Therefore, the covering material can be easily peeled off, and the wound surface is not hurt or suffered. Furthermore, the balance between hydrophilicity and hydrophobicity of the surface of the base material can be easily controlled, and the release of the contained physiologically active substance from the base material can be controlled.

【0013】前記下限温度が0℃より低い高分子を使用
すると、被覆材除去時に皮膚に凍傷を与えるおそれがあ
るので、前述した範囲の下限臨界溶解温度をもつ高分子
が望ましい。
If a polymer having a lower limit temperature lower than 0 ° C. is used, the skin may be frostbite when the coating material is removed. Therefore, a polymer having a lower critical solution temperature in the above range is preferable.

【0014】本発明で被覆に用いられる感応性高分子ま
たはその共重合体は、以下のモノマーの重合または共重
合体により得られる。使用し得るモノマーとしては、例
えばアクリルアミド、メタクリルアミド等の(メタ)ア
クリルアミド化合物、N−イソプロピル(メタ)アクリ
ルアミド、ジエチルアクリルアミド、N−エトキシエチ
ル(メタ)アクリルアミド等のN−アクリル置換(メ
タ)アクリルアミド誘導体、N,N−ジメチル(メタ)
アクリルアミド、N,N−エチルメチルアクリルアミド
等のN,N−ジアルキル置換(メタ)アクリルアミド誘
導体,メチルビニルエーテル等のビニルエーテル誘導体
あるいはメチルセルロース等の水溶性セルロースエーテ
ルなどがあげられるがこれらに限定されない。
The sensitive polymer or its copolymer used for coating in the present invention can be obtained by polymerizing or copolymerizing the following monomers. Examples of the monomer that can be used include (meth) acrylamide compounds such as acrylamide and methacrylamide, N-acryl-substituted (meth) acrylamide derivatives such as N-isopropyl (meth) acrylamide, diethylacrylamide, and N-ethoxyethyl (meth) acrylamide. , N, N-dimethyl (meth)
Examples thereof include, but are not limited to, N, N-dialkyl-substituted (meth) acrylamide derivatives such as acrylamide and N, N-ethylmethylacrylamide, vinyl ether derivatives such as methyl vinyl ether, and water-soluble cellulose ethers such as methyl cellulose.

【0015】下限臨界溶解温度が0〜35℃のものとし
ては、N−イソプロピルアクリルアミドあるいはジエチ
ルアクリルアミドの単独もしくは共重合体が特に好適に
使用される。
As the one having a lower critical solution temperature of 0 to 35 ° C., N-isopropylacrylamide or diethylacrylamide homopolymer or copolymer is particularly preferably used.

【0016】本発明に用いられる膜は多孔質ポリオレフ
ィン膜あるいは多孔質ハロゲン化ポリオレフィン膜であ
り、汎用で低価格な面を考慮すると、ポリエチレン,ポ
リプロピレン、ポリフッ化ビニリデン、ポリ塩化ビニリ
デン、塩素化ポリエチレンなどが好ましい。得られた被
覆材は、空孔率50%以下、平均孔径0.01〜1.0
μm、水蒸気透過率500〜5000g/m2 ・24h
の範囲にあるものがよい。空孔率は多孔質膜の膜厚と乾
燥重量を測定し、メタノールに浸漬した後、水中でメタ
ノールを置換して取り出し、表面の水を拭って膜の湿潤
重量を測定する。膜厚と乾燥重量,原料の比重から乾燥
空孔率を求める。また乾燥重量と湿潤重量から湿潤空孔
率を求める。本発明において使用している空孔率は乾燥
空孔率である。
The membrane used in the present invention is a porous polyolefin membrane or a porous halogenated polyolefin membrane. Considering general-purpose and low cost, polyethylene, polypropylene, polyvinylidene fluoride, polyvinylidene chloride, chlorinated polyethylene, etc. Is preferred. The obtained coating material has a porosity of 50% or less and an average pore diameter of 0.01 to 1.0.
μm, water vapor transmission rate 500-5000g / m 2 · 24h
Those in the range of are preferable. The porosity is measured by measuring the film thickness and dry weight of the porous film, immersing the film in methanol, substituting the methanol in water for removal, and wiping the surface water to measure the wet weight of the film. Calculate the dry porosity from the film thickness, dry weight, and specific gravity of the raw materials. Further, the wet porosity is calculated from the dry weight and the wet weight. The porosity used in the present invention is dry porosity.

【0017】本発明で用いられる生理活性物質は、皮膚
細胞である皮膚細胞と線維芽細胞の増殖を直接的または
間接的に促進しうるものであれば特に制限はなく、イン
シュリン、ハイドロコーチゾン、上皮細胞成長因子(E
GF)、線維芽細胞成長因子(FGF)、ウロガストロ
ン等が挙げられ、特に上皮細胞成長因子(EGF)、ウ
ロガストロンは好適に用いられる。
The physiologically active substance used in the present invention is not particularly limited as long as it can directly or indirectly promote the growth of skin cells and fibroblasts, which are skin cells. Insulin, hydrocortisone, epithelium Cell growth factor (E
GF), fibroblast growth factor (FGF), urogastrone and the like, and epidermal cell growth factor (EGF) and urogastrone are preferably used.

【0018】上皮細胞成長因子(EGF)は、マウス顎
下腺より分離された、上皮細胞の増殖を促進する因子で
あり、マウスEGF(mEGF)は、53個のアミノ酸
からなるペプチドである。皮膚、舌、食道等の上皮組織
の細胞増殖と分化の促進などの作用を有している。
Epidermal growth factor (EGF) is a factor that promotes growth of epithelial cells separated from mouse submandibular gland, and mouse EGF (mEGF) is a peptide consisting of 53 amino acids. It has actions such as promoting cell proliferation and differentiation of epithelial tissues such as skin, tongue and esophagus.

【0019】ウロガストロンは、ヒト尿中より単離され
たヒト上皮細胞増殖因子のことであり、上記マウスEG
Fとは、53個のアミノ酸のうち16個を異にする。ウ
ロガストロンは、胃液分泌抑制作用とともに細胞増殖作
用を有しており、創傷治療薬としての用途が期待されて
いる。
Urogastron is a human epidermal growth factor isolated from human urine, and is the mouse EG described above.
F differs from F by 16 out of 53 amino acids. Urogastron has a cell proliferation action as well as a gastric juice secretion inhibitory action, and is expected to be used as a therapeutic drug for wounds.

【0020】また、インシュリン、ハイドロコーチゾン
等のホルモンは細胞に対する種々の効果、特に細胞増殖
効果が期待されている。なかでもハイドロコーチゾン
は、今や創傷治癒における炎症抑制に欠かせない薬物と
されている。
In addition, hormones such as insulin and hydrocortisone are expected to have various effects on cells, particularly cell growth effects. Among them, hydrocortisone is now regarded as an essential drug for suppressing inflammation in wound healing.

【0021】本発明の創傷被覆材は例えば次のようにし
て製造される。まず、ポリプロピレン粉末に所定量の流
動パラフィン及び結晶核形成剤を加えて溶融混練しペレ
ット化する。このペレットを150〜200℃で溶融
し、Tダイ付押出機により押出し、冷却固定化液中に導
き冷却固定化してフィルムにし、該フィルム中の流動パ
ラフィンの抽出を行い、135℃程度の空気中で約2分
間熱処理を行い、ポリプロピレン製の多孔質膜を得る。
The wound dressing of the present invention is manufactured, for example, as follows. First, a predetermined amount of liquid paraffin and a crystal nucleating agent are added to polypropylene powder, melt-kneaded and pelletized. The pellets are melted at 150 to 200 ° C., extruded by an extruder with a T-die, introduced into a cooling and immobilizing liquid to be cooled and immobilized to form a film, and liquid paraffin in the film is extracted. And heat-treated for about 2 minutes to obtain a polypropylene porous membrane.

【0022】一方、ポリ−N−イソプロピルアクリルア
ミドは水溶液中で約32℃に下限臨界溶解温度を有する
ことが知られている。例えば、上記該ポリプロピレン製
の多孔質膜にポリ−N−イソプロピルアクリルアミドを
被覆すると、下限臨界溶解温度である32℃以上ではポ
リ−N−イソプロピルアクリルアミドの占有体積は少な
くなり、ポリマー中の水分子を隣接するため、基材表面
は疎水性を示し、逆に32℃以下ではポリ−N−イソプ
ロピルアクリルアミドの占有体積は大きくなるので、ポ
リマー中の水分子の占める体積分率が上昇するため、基
材表面は親水性を示すようになる。
On the other hand, poly-N-isopropylacrylamide is known to have a lower critical solution temperature at about 32 ° C. in an aqueous solution. For example, when the polypropylene porous film is coated with poly-N-isopropylacrylamide, the occupied volume of poly-N-isopropylacrylamide becomes small at a lower critical solution temperature of 32 ° C. or higher, and water molecules in the polymer are removed. Since they are adjacent to each other, the surface of the base material is hydrophobic, and conversely, the occupied volume of poly-N-isopropylacrylamide is large at 32 ° C. or lower, so that the volume fraction occupied by water molecules in the polymer is increased. The surface becomes hydrophilic.

【0023】また次の方法により得ることができる。ポ
リプロピレン製の多孔質膜にイソプロピルアルコールに
溶解したN−イソプロピルアクリルアミドをプラズマ開
始表面グラフト重合して得られる。該被覆材を32℃以
下の湿潤環境下に維持したまま、生理活性物質の粉末あ
るいは生理活性物質の水溶液を含浸させ、風乾すること
によって得ることができる。
Further, it can be obtained by the following method. It is obtained by plasma-initiated surface graft polymerization of N-isopropylacrylamide dissolved in isopropyl alcohol on a polypropylene porous membrane. It can be obtained by impregnating a powder of a physiologically active substance or an aqueous solution of a physiologically active substance with the coating material kept in a humid environment of 32 ° C. or lower and air-drying.

【0024】[0024]

【実施例】以下、実施例および実験例を示して本発明を
さらに具体的に説明する。
EXAMPLES The present invention will be described more specifically below with reference to examples and experimental examples.

【0025】実施例1 (1)ポリ−N−イソプロピルアクリルアミドの合成 N−イソプロピルアクリルアミド(東京化成(株))は
トルエンに溶解させ、石油エーテルで再沈精製した。精
製したN−イソプロピルアクリルアミド20gをベンゼ
ン溶液30mlに溶解させ、開始剤アゾビスイソブチロニ
トリル0.08gを加えた。窒素気流下で反応温度60
℃、反応時間24時間撹拌して重合した。この重合物を
THFに溶解させ、エチルエーテルで再沈した。上記の
再沈精製操作を2回繰り返した。更に、室温中で72時
間、真空乾燥することにより目的物16gを得ることが
できた。
Example 1 (1) Synthesis of poly-N-isopropylacrylamide N-isopropylacrylamide (Tokyo Kasei Co., Ltd.) was dissolved in toluene and reprecipitated and purified with petroleum ether. 20 g of purified N-isopropylacrylamide was dissolved in 30 ml of a benzene solution, and 0.08 g of azobisisobutyronitrile as an initiator was added. Reaction temperature 60 under nitrogen stream
Polymerization was carried out by stirring at a reaction temperature of 24 hours for 24 hours. This polymer was dissolved in THF and reprecipitated with ethyl ether. The above reprecipitation purification operation was repeated twice. Furthermore, 16 g of the target product could be obtained by vacuum drying at room temperature for 72 hours.

【0026】(2)多孔質膜の作成 メルトフローインデックスが30及び0.3のポリプロ
ピレン混合物(混合重量比100:40)100重量部
当り、400重量部の流動パラフィン(平均分子量32
4)及び0.3重量部の結晶核形成剤としての1,3,
2,4−ビス(p−エチルベンジリデン)ソルビトール
を二軸型押出機により溶融混練し、ペレット化した。こ
のペレットを上記二軸型押出機を用いて150〜200
℃で溶融し、スリット0.6mmのTダイより空気中に押
出しフィルム状にし、このフィルム状物をTダイ直下に
置かれたガイドローラーによって冷却固定化液中に導き
冷却固定化した後巻取る。この巻取ったフィルム状物を
一定寸法に切断し、縦横両方向に固定し、1,1,2−
トリクロロ−1,2,2−トリフルオロエタン中に10
分間計4回浸漬して、フィルム状物中の流動パラフィン
の抽出を行う。次いで135℃の空気中で2分間熱処理
を行って、孔径0.6μm、膜厚100μmのポリプロ
ピレン製多孔質膜を得た。
(2) Preparation of Porous Membrane 400 parts by weight of liquid paraffin (average molecular weight 32) per 100 parts by weight of a polypropylene mixture having a melt flow index of 30 and 0.3 (mixing weight ratio 100: 40).
4) and 0.3 parts by weight of 1,3 as crystal nucleating agent
2,4-bis (p-ethylbenzylidene) sorbitol was melt-kneaded by a twin-screw extruder and pelletized. The pellets were heated to 150 to 200 by using the above twin-screw extruder.
It is melted at ℃, extruded into air from a T-die with a slit of 0.6 mm, and made into a film shape. This film-like material is introduced into a cooling immobilization solution by a guide roller placed directly under the T-die, cooled and fixed, and then wound up. .. The wound film-like material is cut into a certain size and fixed in both longitudinal and lateral directions,
10 in trichloro-1,2,2-trifluoroethane
The liquid paraffin in the film-like material is extracted by immersing it 4 times in total. Then, heat treatment was performed in air at 135 ° C. for 2 minutes to obtain a polypropylene porous film having a pore size of 0.6 μm and a film thickness of 100 μm.

【0027】(3)創傷被覆材の作成 上記(1)で合成した2%ポリ−N−イソプロピルアク
リルアミドのエタノール溶液を実施例2で作成したポリ
プロピレン製多孔質膜に被覆した後、クリーンベンチ内
で風乾して得た。
(3) Preparation of Wound Dressing Material The polypropylene porous membrane prepared in Example 2 was coated with the ethanol solution of 2% poly-N-isopropylacrylamide synthesized in (1) above, and then in a clean bench. Obtained by air-drying.

【0028】実施例2 創傷被覆材の作成 実施例1(2)で作成したポリプロピレン製多孔質膜に
1分間アルゴンプラズマを照射させ、5%のN−イソプ
ロピルアクリルアミドのイソプロピルアルコール溶液中
に浸漬させ、30分間グラフト重合を行って得た。
Example 2 Preparation of Wound Dressing The polypropylene porous membrane prepared in Example 1 (2) was irradiated with argon plasma for 1 minute and immersed in a 5% N-isopropylacrylamide isopropyl alcohol solution. It was obtained by carrying out graft polymerization for 30 minutes.

【0029】実施例3 創傷被覆材の作成 上記実施例2で得られた創傷被覆材を上皮細胞成長因子
を含有したりん酸緩衝液に浸漬させ、20℃で2時間処
理した。更に溶液を37℃に温度を上げてから取り出
し、クリーンベンチ内で風乾した。
Example 3 Preparation of Wound Dressing The wound dressing obtained in Example 2 above was dipped in a phosphate buffer containing epidermal growth factor and treated at 20 ° C. for 2 hours. Further, the temperature of the solution was raised to 37 ° C., taken out, and air-dried in a clean bench.

【0030】実施例4 多孔質膜の作成 プロピレンとエチレンのランダムコポリマー(三井東圧
化学(株))100重量部当り、300重量部の流動パ
ラフィン(平均分子量324)及び0.3重量部の結晶
核形成剤としての1,3,2,4−ビス(p−エチルベ
ンジリデン)ソルビトールを2軸型押出機により溶融混
練し、ペレット化した。このペレットを上記二軸型押出
機を用いて150〜200℃で溶融し、スリット0.6
mmのTダイより空気中に押出しフィルム状にし、このフ
ィルム状物をTダイ直下に置かれたガイドローラーによ
って冷却固定化液中に導き、冷却固定化した後、巻取
る。この巻取ったフィルム状物を一定寸法に切断し、縦
横両方向に固定し、1,1,2−トリクロロ−1,2,
2−トリフルオロエタン中に10分間計4回浸漬して、
フィルム状物中の流動パラフィンの抽出を行って、空孔
率45%,孔径0.07μmのポリオレフィン製多孔質
膜を得た。
Example 4 Preparation of Porous Membrane 300 parts by weight of liquid paraffin (average molecular weight 324) and 0.3 parts by weight of crystals per 100 parts by weight of a random copolymer of propylene and ethylene (Mitsui Toatsu Chemicals, Inc.). 1,3,2,4-bis (p-ethylbenzylidene) sorbitol as a nucleating agent was melt-kneaded by a twin-screw extruder and pelletized. The pellets were melted at 150 to 200 ° C. using the above-mentioned twin-screw extruder and slit 0.6
A film is extruded in the air from a T-die of mm, and the film-like material is introduced into a cooling and immobilizing solution by a guide roller placed immediately below the T-die, cooled and immobilized, and then wound. This wound film-like material is cut into a certain size, fixed in both the vertical and horizontal directions, and 1,1,2-trichloro-1,2,2,
Dip in 2-trifluoroethane for a total of 4 times for 10 minutes,
Liquid paraffin in the film was extracted to obtain a polyolefin porous membrane having a porosity of 45% and a pore diameter of 0.07 μm.

【0031】実施例5 創傷被覆材の作成 上記実施例1(1)で合成した2%ポリ−N−イソプロ
ピルアクリルアミドのエタノール溶液を実施例4で作成
したポリオレフィン製多孔質膜に被覆した後、クリーン
ベンチ内で風乾して得た。
Example 5 Preparation of Wound Dressing Material The polyolefin porous membrane prepared in Example 4 was coated with the ethanol solution of 2% poly-N-isopropylacrylamide synthesized in Example 1 (1) above, and then clean. Obtained by air-drying on the bench.

【0032】実施例6 創傷被覆材の作成 実施例5で作成したポリオレフィン製多孔質膜に1分間
アルゴンプラズマを照射させ、5%のN−イソプロピル
アクリルアミドのイソプロピルアルコール溶液中に浸漬
させ、30分間グラフト重合を行って得た。
Example 6 Preparation of Wound Dressing Material The polyolefin porous membrane prepared in Example 5 was irradiated with argon plasma for 1 minute, immersed in a 5% N-isopropylacrylamide isopropyl alcohol solution, and grafted for 30 minutes. It was obtained by polymerization.

【0033】実施例7 創傷被覆材の作成 上記実施例6で得られた創傷被覆材を上皮細胞成長因子
を含有したりん酸緩衝液に浸漬させ、20℃で2時間処
理した。更に溶液を37℃に温度を上げてから取り出
し、クリーンベンチ内で風乾した。
Example 7 Preparation of Wound Dressing The wound dressing obtained in Example 6 above was immersed in a phosphate buffer containing epidermal growth factor and treated at 20 ° C. for 2 hours. Further, the temperature of the solution was raised to 37 ° C., taken out, and air-dried in a clean bench.

【0034】実施例(動物実験) 創傷被覆材のラット皮膚欠損創の移植 上記で得られた被覆材をラットの背部皮膚に移植して試
験した。Wistar−KYラット(200〜400
g)をネンブタール麻酔下で除毛し、イソジン消毒した
ラット背部皮膚にデルマトームで12/1000(イン
チ)の皮膚を剥離して欠損創を作製し、止血、乾燥した
後、生食を含ませた検体をそれぞれ貼付し、4隅をアロ
ンアルファで固定した。その上に、ソルフレン(テルモ
製)を4枚重ね、更にエラスチコン等の伸縮性絆創膏で
胴巻にし圧迫固定した。
Example (animal experiment) Transplantation of rat skin defect wound with wound dressing The dressing obtained above was transplanted to the back skin of a rat and tested. Wistar-KY rat (200-400
(g) was shaved under Nembutal anesthesia, 12/1000 (inch) of skin was peeled with a dermatome on the rat dorsal skin that had been disinfected with isodine to create a defect wound, which was bleeding stopped, dried, and a sample containing saline was added. Was affixed, and the four corners were fixed with Aron Alpha. On top of that, 4 sheets of Solfuren (made by Terumo) were stacked, and then stretched with elastic bandages such as Elasticon to be wrapped in a body and pressed and fixed.

【0035】移植後1日目で創傷被覆材の交換をする為
に、剥がす前に予め冷媒他の凍結物で創傷被覆材を冷し
てやると、創面を傷つけずに容易に剥がすことができ
た。
To replace the wound dressing on the first day after transplantation, if the wound dressing was previously cooled with a frozen substance such as a refrigerant before peeling, it could be easily peeled off without damaging the wound surface.

【0036】[0036]

【発明の効果】本発明の創傷被覆材は、創傷と接触する
面に、水に対する上限臨界溶解温度が40〜50℃の範
囲にあるか、あるいは下限臨界溶解温度が0〜35℃の
範囲にある温度感応性高分子が被覆されているので、被
覆材が創面に適用されているときは、該高分子が固体状
に保持され、創面を保護し、他方、剥離時に被覆材を上
記の範囲の温度に加温または冷却することにより上記高
分子が水に溶け、容易に被覆材を除去することができ
る。
EFFECT OF THE INVENTION The wound dressing of the present invention has an upper critical solution temperature in water in the range of 40 to 50 ° C. or a lower critical solution temperature in the range of 0 to 35 ° C. on the surface in contact with the wound. Since a certain temperature-sensitive polymer is coated, when the coating material is applied to the wound surface, the polymer is held in a solid state and protects the wound surface, while the coating material is kept in the above range when peeling. By heating or cooling to the above temperature, the above polymer dissolves in water and the coating material can be easily removed.

フロントページの続き (72)発明者 大西 誠人 神奈川県足柄上郡中井町井ノ口1500番地 テルモ株式会社内 (72)発明者 志村 賢一 神奈川県足柄上郡中井町井ノ口1500番地 テルモ株式会社内Front page continued (72) Inventor Makoto Onishi, 1500 Inoguchi, Nakai-cho, Ashigagami-gun, Kanagawa Terumo Corporation (72) Inventor Kenichi Shimura 1500, Inoguchi, Nakai-cho, Ashigagami-gun, Kanagawa Terumo Corporation

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 多孔質ポリオレフィン膜あるいは多孔質
ハロゲン化ポリオレフィン膜の一方の表面に、水に対す
る下限臨界溶解温度が0〜35℃の範囲にある温度感応
性高分子を被覆してなる創傷被覆材。
1. A wound dressing material comprising one surface of a porous polyolefin membrane or a porous halogenated polyolefin membrane coated with a temperature-sensitive polymer having a lower critical solution temperature in the range of 0 to 35 ° C. in water. ..
【請求項2】 空孔率50%以下、平均孔径0.01〜
1.0μmである多孔質ポリオレフィン膜あるいは多孔
質ハロゲン化ポリオレフィン膜からなり、その表面およ
び孔内面を、水に対する下限臨界溶解温度が0〜35℃
の範囲にある温度感応性高分子で被覆してなる創傷被覆
材。
2. A porosity of 50% or less and an average pore diameter of 0.01 to.
It is composed of a porous polyolefin membrane or a porous halogenated polyolefin membrane having a thickness of 1.0 μm, and has a lower critical dissolution temperature in water of 0 to 35 ° C. on its surface and pore inner surface.
A wound dressing material coated with a temperature-sensitive polymer in the range of.
【請求項3】 請求項1の創傷被覆材に生理活性物質を
含有させた創傷被覆材。
3. A wound dressing containing the wound dressing of claim 1 containing a physiologically active substance.
JP27182291A 1991-09-25 1991-09-25 Wound coating material Pending JPH0584289A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP27182291A JPH0584289A (en) 1991-09-25 1991-09-25 Wound coating material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27182291A JPH0584289A (en) 1991-09-25 1991-09-25 Wound coating material

Publications (1)

Publication Number Publication Date
JPH0584289A true JPH0584289A (en) 1993-04-06

Family

ID=17505336

Family Applications (1)

Application Number Title Priority Date Filing Date
JP27182291A Pending JPH0584289A (en) 1991-09-25 1991-09-25 Wound coating material

Country Status (1)

Country Link
JP (1) JPH0584289A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1072617A1 (en) * 1999-07-30 2001-01-31 Universiteit van Utrecht Temperature sensitive polymers

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1072617A1 (en) * 1999-07-30 2001-01-31 Universiteit van Utrecht Temperature sensitive polymers
WO2001009198A1 (en) * 1999-07-30 2001-02-08 Stichting Voor De Technische Wetenschappen Temperature sensitive polymers

Similar Documents

Publication Publication Date Title
KR100748348B1 (en) Method for the preparation of hydrogels for wound dressing using radiation irradiation
EP1259269A1 (en) Agent for the treatment of wounds
Shyna et al. A nonadherent chitosan-polyvinyl alcohol absorbent wound dressing prepared via controlled freeze-dry technology
JPH06504932A (en) wound dressing
DK154806B (en) PROCEDURE CONTAINING AN ACTIVE SUBSTANCE FOR PROMOTING SEARCH AND PROCEDURE FOR PREPARING THEREOF
JP2001506908A (en) Absorbable hydrogel particles and their use in wound dressings
EP3145556A1 (en) Apertured hydrogel compositions and wound dressings
WO2015103988A1 (en) Medical dressing hydrogel composite fabric, and preparation method therefor and uses thereof
JP4783285B2 (en) Therapeutic thermosensitive polymers and methods of preparation
HU180013B (en) Semi-transparent,liquide-containing bandage and process for producing them
Ning et al. Effect of hydrogel grafting, water and surfactant wetting on the adherence of PET wound dressings
KR20030060458A (en) Method for the preparation of hydrogels for wound dressings
CN113144280B (en) Intelligent antibacterial hydrogel and application thereof
JPH04303445A (en) Wound covering material
WO2009019485A2 (en) A wound dressing
JPH06233809A (en) Wound cladding material
JPH0584289A (en) Wound coating material
RU2372944C2 (en) Wound healing coating
JP2006271927A (en) Wound covering composition and sheet-like wound covering material
JP3026316B2 (en) Hydrogel for wound dressing
JPH05192363A (en) Wound covering material
US20020028232A1 (en) Wound dressing
JPH08103490A (en) Water absorbent polymer for medical treatment and coating material for wound formed by using the same and external material for medical treatment and their production
JPH0584288A (en) Wound coating material
JP2017080116A (en) Medical member